The Food and Drug Administration issued authorization granting the emergency use approval of COVID-19 drug Molnupiravir with Conditional Marketing Authorization to the following:

 

• Faberco Life Sciences Inc. – Molnarz
• MedEthix Inc. – Molnaflu
• German Quality Pharma Inc. – Auxilto
• Lloyd Laboratories Inc and Dr. Zen’s Research Inc. – Molnupiravir
• Sun Pharma Philippines Inc. – Molxvir
• Mylan Philippines Inc. – Molnatris
• MedEthix Inc. – Molena
  
• Sahar International Trading, Inc. – Molenzavir
• Biocare Lifescience Inc. – Cipmolnu
• Torrent Pharma Philippines Inc. – Molnutor
• Dr. Reddy’s Laboratories Philippines, Inc – Molnupiravir
• Ambicare Pharmaceuticals, Inc. – Molnuzen
• Camber Pharmaceuticals, Inc. – Movfor
• Khriz Pharma Trading, Inc. – Monuvir
• Buergli Pharma, Inc. – Molcovir
  
  

Product Information

  English

For more information on reporting side effects, click here.